logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Innate Tumor Immunity, Inc.


USPTO Granted Patents = 21


Forward Citations = 38

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Shomir Ghosh (13 out of 71 patents)

silverMedal William R Roush (13 out of 36 patents)

bronzeMedal Gary D Glick (10 out of 66 patents)

4.  Daniel O'Malley (9 out of 17 patents)

5.  Ashvinikumar V Gavai (9 out of 59 patents)

6.  Edward James Olhava (9 out of 45 patents)

7.  Scott Hunter Watterson (6 out of 41 patents)

8.  Hua Gong (6 out of 13 patents)

9.  Christine M Tarby (5 out of 21 patents)

10.  Patrice Gill (4 out of 15 patents)

11.  Yong Zhang (4 out of 30 patents)

12.  Roger A Jones (4 out of 15 patents)

13.  David K Williams (3 out of 30 patents)

14.  Steven P Seitz (3 out of 31 patents)

15.  Sha Lou (2 out of 4 patents)


21 patents:

1. 12391675 - NLRP3 modulators (2025-08-19),
2. 12351580 - NLRP3 modulators (2025-07-08),
3. 12338228 - NLRP3 modulators (2025-06-24),
4. 12201627 - NLRP3 modulators (2025-01-21),
5. 12187706 - NLRP3 modulators (2025-01-07),
6. 12171756 - NLRP3 modulators (2024-12-24),
7. 12150937 - NLRP3 modulators (2024-11-26),
8. 12037344 - NLRP3 modulators (2024-07-16),
9. 12024513 - NLRP3 modulators (2024-07-02),
10. 11827632 - NLRP3 modulators (2023-11-28),
11. 11827597 - Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparation (2023-11-28),
12. 11572360 - Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparation (2023-02-07),
13. 11505571 - Compounds and compositions for treating conditions associated with sting activity (2022-11-22),
14. 11344543 - NLRP3 modulators (2022-05-31),
15. 11072612 - NLRP3 modulators (2021-07-27),
Company Overview
Innate Tumor Immunity, Inc. is a biotechnology company based in Princeton, NJ, focused on advancing cancer treatment through innovative immunotherapy solutions. The organization specializes in harnessing the body's innate immune system to target and eliminate tumor cells, aiming to improve patient outcomes in oncology. With a commitment to research and development, Innate Tumor Immunity is dedicated to exploring novel therapeutic approaches that leverage immune responses, contributing to the evolving landscape of cancer therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

21 Patents

#44 in Princeton, NJ

#602 in New Jersey

#15,695 in US

#29,961 in the World

Princeton, NJ (US)
Princeton, NJ, United States of America

Innate Tumor Immunity, Inc.

Forward Citations = 38

25 inventors:

goldMedal Shomir Ghosh (13 out of 71 patents)

silverMedal William R Roush (13 out of 36 patents)

bronzeMedal Gary D Glick (10 out of 66 patents)

4.  Daniel O'Malley (9 out of 17 patents)

5.  Ashvinikumar V Gavai (9 out of 59 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innate Tumor Immunity, Inc.. Retrieved from https://idiyas.com/company/innate-tumor-immunity

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…